I listen carefully to clients in order to understand their business and goals in detail to deliver successful outcomes and build lasting relationships.
Stephen provides mergers and acquisitions (M&A) advisory services within the healthcare industry to owner managed and private equity-backed businesses and private equity clients.
Stephen has experience working on sell-side and buy-side transactions in the IVF, dental and veterinary sectors amongst others.
Prior to joining Lincoln, Stephen was a Manager at IBI Corporate Finance, Ireland’s leading corporate finance advisory firm, advising on M&A for public, private and semi-state entities. Prior to this, Stephen was an Analyst in the financial services practice of Accenture.
Stephen graduated with a Bachelor of Chemical Engineering from University College Dublin. He is a CFA charterholder.
Recent Transactions in Healthcare
Lincoln International advised Veritas Capital on the acquisition of Coronis Health and MiraMed Global Services
Lincoln International advised Perwyn on the acquisition of European Sperm Bank from Axcel
Lincoln International advised Quartz Healthcare, a portfolio company of InfraVia, on the acquisition of radprax from its private shareholders
Lincoln International advised ArchiMed and management on the sale of EUROLyser to Antech Diagnostics, a subsidiary of Mars Veterinary Health
Lincoln International advised G Square on its merge and refinancing of Accomplish and Keys Group into a continuation vehicle
Lincoln International advised Pharos Capital Group on the sale of TechLab to SSI Diagnostica, a portfolio company of Adelis Equity Partners
Lincoln International advised Lab Logistics, a portfolio company of Atlantic Street Capital, on receiving a minority investment from Linden Capital Partners
Lincoln International advised Hartenberg Holding on the sale of a minority stake in FutureLife to CVC
Related Perspectives in Healthcare
A New Standard for Beauty and Apparel: Inclusive Products and Sustainable Brands
Investor interest in environmental, social and governance (ESG) increases daily. As a result, companies and brands are now being called upon to prioritize ESG activities in an authentic and transparent… Read More
Reality Check: Assessing Private Equity’s 2022 Predictions
In Q4 2021, Lincoln International surveyed nearly 400 private equity investors on their expectations for dealmaking in the year ahead. In the three quarters since, public equity markets have seen… Read More
Discovering the Investment Opportunity in Pre-Clinical CROs
The process to bring a drug to market is likely to be extensive and costly, from the starting points of research and development (R&D) across all phases of clinical trials… Read More
Lincoln Private Market Index Experiences First Decline Since Q1 2020
Public market volatility driven by heightened recession fears trickled to private market enterprise values in Q2 The Lincoln Private Market Index (Lincoln PMI), the only index that tracks changes in… Read More
Meet our Senior Team in Healthcare
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Managing Director | Management Board MemberFrankfurt